Literature DB >> 2181490

A role for 5-HT in the action of antidepressant drugs.

P J Cowen1.   

Abstract

Administration of antidepressant drugs to rodents appears to decrease 5-HT2 receptor function while transmission through postsynaptic 5-HT1 receptor synapses may be enhanced. Antidepressant drugs also alter 5-HT mechanisms in humans; some of these changes are congruent with effects noted in animal studies. Thus certain 5-HT-mediated neuroendocrine responses are enhanced by tricyclic antidepressants and monoamine oxidase inhibitors, and it seems likely that tricyclics may act as 5-HT2 receptor antagonists in the human brain. However, there is presently no firm evidence that any of these changes are necessary for the clinical efficacy of antidepressant drugs. The best evidence that 5-HT neurons may be involved in mediating antidepressant effects is the antidepressant activity of selective 5-HT uptake blockers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181490     DOI: 10.1016/0163-7258(90)90033-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  8 in total

1.  The GABA(A) receptor complex as a target for fluoxetine action.

Authors:  G Tunnicliff; N L Schindler; G J Crites; R Goldenberg; A Yochum; E Malatynska
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

2.  Platelet serotonin and interleukin-1 beta after sleep deprivation and recovery sleep in humans.

Authors:  P Heiser; B Dickhaus; C Opper; W Schreiber; H W Clement; C Hasse; J Hennig; J C Krieg; W Wesemann
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

Authors:  J L Moreau; F Jenck; J R Martin; S Perrin; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

Authors:  D D Dougherty; C E Sortwell; J Sagen
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 5.  Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

Authors:  Lee A Dawson; Jeannette M Watson
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

6.  The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; S M Candura; M Tonini
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

7.  Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour.

Authors:  P S Whitton; G S Sarna; K P Datla; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.

Authors:  Kimberly R Tyeryar; Ashiwel S Undie
Journal:  Psychopharmacology (Berl)       Date:  2007-04-15       Impact factor: 4.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.